As rare disease trials face persistent feasibility challenges, Bayesian designs are gaining momentum by enabling more ...

This transition is explored in “Embodied Artificial Intelligence in Healthcare: A Systematic Review of Robotic Perception, ...

Divergence in the post-progression interval suggests disparities may concentrate in subsequent-line therapy, surveillance, supportive care, or access to timely interventions outside trial ...

In an interview, C. Ola Landgren, MD, PhD, delved into the details of the FDA's draft guidance on using MRD as a basis for ...

Transcript: Rare Diseases ...

An optimal PSA response, defined as ≤0.2 ng/mL, is achieved by approximately 51% of mHSPC patients 6–8 months after treatment with androgen deprivation therapy (ADT) and androgen receptor pathway ...

A phase 2 trial showed that combining targeted radiotherapy with PD-1 blockade and a bevacizumab biosimilar can elicit responses in advanced liver cancer.

Anticoagulation is a critical component in the treatment of cardiovascular diseases. Large randomised controlled trials have ...

Introduction Burnout among healthcare professionals remains a critical public health issue linked to impaired cognition, emotional exhaustion and diminished clinical performance. Structured breathing ...

Hinge is for daters in their 20s and 30s who are completely over swipe culture and want a real, meaningful relationship. It's ...

Cardiovascular Research  (CVR) is an official, international, peer-reviewed journal of the European Society of Cardiology  (ESC), dedicated to basic discovery and translational research on all topics ...